ArticleACS medicinal chemistry letters2022

Fragment-Based Discovery of a Novel, Brain Penetrant, Orally Active HDAC2 Inhibitor.

Emiliano Tamanini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.